02186.HK
Luye Pharma Group Ltd.
HKSE · Healthcare · Drug Manufacturers - General · CN
HKD 1.75
+2.94%Margins
Gross margin
63.7%
EBITDA margin
36.2%
EBIT margin
22.7%
Net margin
11.3%
FCF margin
6.8%
4.4%
Return on equity
2.0%
Return on assets
4.9%
Return on invested capital
0.18x
Asset turnover
HKD 407.4M
Cash from operations
HKD 3.85
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026